ARQT vs POOL · rev $196.5M vs P/E 18, rev $5.31B
Arcutis Biotherapeutics Inc (ARQT) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ARQT currently screens at market cap $1.64B. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ARQT and POOL stock pages for the full models.
Not investment advice.